Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2023 - Volume 27, Number 1
View All Articles in Issue

Page(s): 53

Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus Page 1

Download in electronic PDF format for $65

Abstract: A formulation for preparing Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, erlotinib, formulations, oral suspensions, antineoplastic agent, epidermal growth factor receptor inhibitor, EGF receptor blocker, anticancer agent, cancer, tumor

Related Categories: CANCER AND AIDS, EXCIPIENTS, FORMULATIONS, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Jan/Feb 2023 Pg. 53
Compounding with Biotechnology Products, Part 2: Product-specific Considerations Allen Loyd V Jr	Nov/Dec 2022 Pg. 446-466
Imatinib 40-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 510
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Erlotinib 10-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 508
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Compounding for the Effects of Weapons of Mass Destruction Sammarco Domenic A	Jan/Feb 2003 Pg. 10-15 View Sample
Sunitinib 10-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2010 Pg. 248
Granisetron Hydrochloride 0.2-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 419